To investigate the mechanism underlying TSA facilitation of ESCC cell migration, the levels of phosphorylated ERK1/2 (p‐ERK1/2) and the active form of ERK1/2, were examined in TSA‐treated ESCC cells. This evidence concerns the gene MAPK3 and esophageal squamous cell carcinoma.